Exact Sciences Corp (NAS:EXAS)
$ 49.84 -4.24 (-7.84%) Market Cap: 9.20 Bil Enterprise Value: 11.10 Bil PE Ratio: 0 PB Ratio: 2.93 GF Score: 80/100

Q3 2020 Exact Sciences Corp Earnings and Agreement to Acquire Thrive Earlier Detection Corp - Conference Call Transcript

Oct 27, 2020 / 12:00PM GMT
Release Date Price: $131.12 (+23.04%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Exact Sciences Agreement to Acquire Thrive and Third Quarter Earnings Results. (Operator Instructions) I would now like to turn the call over to your speaker today, Megan Jones, Director of Investor Relations. Please go ahead.

Megan Jones
Exact Sciences Corporation - Associate Manager of IR

Thank you, and good morning. Welcome to our conference call to discuss Exact Sciences' acquisition of Thrive, which we announced earlier this morning. In conjunction with today's announcement, Exact Sciences issued financial results for the third quarter of 2020, which are available on our website.

During today's call, we will make forward-looking statements based on current expectations. Our actual results may be materially different from such statements. Descriptions of the risks and uncertainties associated with Exact Sciences are included in our SEC filings, which can be accessed through our website. These forward-looking statements are not guarantees of future performance or events, and actual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot